AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Ceftriaxone And Sulbactam
9 registrations across 2 African markets— 9 active
Markets with Ceftriaxone And Sulbactam
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Avicef Forte Injection_ Injection | 🇳🇬Nigeria | Tyonex Nigeria Limited | active | Oct 2030 |
| Curamus Ceftriaxone and Sulbactam for Injection 1.5 g_ Injection | 🇳🇬Nigeria | Curamus Helt Limited | active | Oct 2030 |
| Oframax S Injection 1500 mg** Powder for injection | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | Oct 2030 |
| Fredacef IV Injection Powder for injection | 🇳🇬Nigeria | Fredan Pharmaceutical Nig Ltd | active | Apr 2030 |
| ALCEF-SB Dry powder for Injection | 🇹🇿Tanzania | Neomedic Limited | active | — |
| G-CEFTRIA PLUS Powder and solvent for solution for injection | 🇹🇿Tanzania | B&O PHARM | active | — |
| Ceftatime-SB 1.5 Powder for solution for injection | 🇹🇿Tanzania | Mankind Pharma Limited | active | — |
| GENCEF PLUS Dry powder for Injection | 🇹🇿Tanzania | GENERICS & SPECIALITIES LTD | active | — |
| Neomicef-S 1.5G Injection | 🇹🇿Tanzania | Neomi Pharmaceuticals Pvt. Ltd | active | — |
Ceftriaxone And Sulbactam in Africa — Regulatory Overview
Ceftriaxone And Sulbactam is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.